Aspirin Or Warfarin To Prevent Stroke
NCT00004728 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2006-06-06
Summary
The purpose of this study is to determine whether aspirin or warfarin is more effective in preventing stroke in patients with intracranial stenosis.
Conditions
- Stroke
- Cerebral Infarction
- Atherosclerosis
- Constriction, Pathologic
Interventions
- DRUG
-
Warfarin
- DRUG
Sponsors & Collaborators
-
National Institute of Neurological Disorders and Stroke (NINDS)
lead NIH
Principal Investigators
-
Marc Chimowitz · Emory University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Completion
- 2003-07-31
Countries
- United States
Study Locations
More Related Trials
-
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
NCT00041938 ·Status: COMPLETED ·Phase: PHASE3
-
Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II
NCT04078737 ·Status: COMPLETED ·Phase: PHASE3
-
PPARGC1β and CNTN4 Genotype Aspirin Study
NCT02970604 ·Status: UNKNOWN ·Phase: PHASE4
-
Perioperative Aspirin Response in Patients Undergoing Vascular Surgery
NCT03587324 ·Status: COMPLETED ·Phase: NA
-
Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy
NCT07086183 ·Status: NOT_YET_RECRUITING
-
Recurrent Carotid Stenosis
NCT00000527 ·Status: COMPLETED ·Phase: PHASE2
-
Warfarin and Antiplatelet Vascular Evaluation
NCT00125671 ·Status: UNKNOWN ·Phase: PHASE3
-
Association of PeriOPerative Aspirin-ResisTance and CardioVascular Outcome
NCT04053894 ·Status: UNKNOWN
-
The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack
NCT02144831 ·Status: WITHDRAWN ·Phase: PHASE4
-
ASA- and Clopidogrel-Responsiveness in Patients With Peripheral Arterial Occlusive Disease and Interventional Procedures
NCT00593762 ·Status: SUSPENDED
-
Aspirin Treatment for Small Unruptured InTracranial Aneurysms With Ischemic cereBrovascuLar diseasE
NCT05907902 ·Status: UNKNOWN ·Phase: PHASE3
-
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
NCT00412984 ·Status: COMPLETED ·Phase: PHASE3
-
Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease
NCT01668901 ·Status: WITHDRAWN ·Phase: PHASE4
-
Asymptomatic Carotid Artery Plaque Study (ACAPS)
NCT00000469 ·Status: COMPLETED ·Phase: PHASE2
-
INdobufen Versus asPirin in Endovascular Unruptured Intracranial Aneurysms Treatment (INPUT)
NCT07089862 ·Status: RECRUITING ·Phase: NA
-
Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events
NCT01586975 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Perioperative Bleeding and Aspirin Use in Spine Surgery
NCT02807441 ·Status: WITHDRAWN ·Phase: PHASE3
-
Platelet Hyperreactivity to Aspirin and Stroke
NCT00766896 ·Status: COMPLETED ·Phase: PHASE4
-
Aortic Arch Related Cerebral Hazard Trial (ARCH)
NCT00235248 ·Status: COMPLETED ·Phase: PHASE3
-
Aspirin Statins Or Both For The Reduction Of Thrombin Generation In Diabetic People
NCT00793754 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk
NCT02960126 ·Status: UNKNOWN ·Phase: PHASE3
-
DS1040b/Aspirin Drug/Drug Interaction Study
NCT02071004 ·Status: COMPLETED ·Phase: PHASE1
-
Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling
NCT05257824 ·Status: COMPLETED ·Phase: PHASE4
-
NOACs for Stroke Prevention in Patients With Atrial Fibrillation and Previous ICH
NCT02998905 ·Status: COMPLETED ·Phase: PHASE2
-
High-Shear Microfluidic Thrombosis Assay
NCT02422810 ·Status: COMPLETED